Fifty patients with primary hyperparathyroidism were studied with an oral calcium-tolerance test, measurements of plasma levels of vitamin D metabolites, and determination of calcium excretion on both a low-normal (400 mg) and high-normal (1000 mg) calcium intake. There were strong positive correlations between plasma levels of 1,25-dihydroxyvitamin D (1,25(OH)2D) and both the calciuric response to the calcium-tolerance test (r = +0.75, P less than 0.001) and calcium excretion on the 1000-mg calcium diet (r = +0.65, P less than 0.001). The patients were classified into two subpopulations: 30 patients showed hyperabsorption with the calcium-tolerance test, striking hypercalciuria, marked elevations in plasma 1,25(OH)2D, and a high incidence (19 of 30 patients) of renal stones; 20 patients had a normal response to the tolerance test, normocalciuria, normal or high-normal plasma 1,25(OH)2D, and a low incidence of stones (three of 20 patients). The findings emphasize the importance of circulating 1,25(OH)2D in the pathogenesis of hypercalciuria and stone formation in primary hyperparathyroidism.
This article has been cited by other articles:
HALL, P. M.
(2009). Nephrolithiasis: Treatment, causes, and prevention. Cleveland Clinic Journal of Medicine
76: 583-591
[Abstract][Full Text]
O'Brien, C. A., Jilka, R. L., Fu, Q., Stewart, S., Weinstein, R. S., Manolagas, S. C.
(2005). IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am. J. Physiol. Endocrinol. Metab.
289: E784-E793
[Abstract][Full Text]
Tebben, P. J., Singh, R. J., Clarke, B. L., Kumar, R.
(2004). Fibroblast Growth Factor 23, Parathyroid Hormone, and 1{alpha},25-Dihydroxyvitamin D in Surgically Treated Primary Hyperparathyroidism. Mayo Clin Proc.
79: 1508-1513
[Abstract]
Singh, R. J., Kumar, R.
(2003). Fibroblast Growth Factor 23 Concentrations in Humoral Hypercalcemia of Malignancy and Hyperparathyroidism. Mayo Clin Proc.
78: 826-829
[Abstract]
Wilson, R. J., Rao, D. S., Ellis, B., Kleerekoper, M., Parfitt, A. M.
(1988). Mild Asymptomatic Primary Hyperparathyroidism Is Not a Risk Factor for Vertebral Fractures. ANN INTERN MED
109: 959-962
[Abstract]
DORSCH, T. R.
(1986). The Milk-Alkali Syndrome, Vitamin D, and Parathyroid Hormone. ANN INTERN MED
105: 800-801
[Abstract]
Santos, F., Smith, M. J. V., Chan, J. C. M.
(1986). Hypercalciuria Associated With Long-term Administration of Calcitriol (1,25-Dihydroxyvitamin D3) Action of Hydrochlorothiazide. Arch Pediatr Adolesc Med
140: 139-142
[Abstract]
KITOH, C.
(1985). Lymphoma, Hypercalcemia, and Serum Calcitriol Levels. ANN INTERN MED
103: 152-153
[Abstract]
ORWOLL, E. S.
(1982). The Milk-Alkali Syndrome: Current Concepts. ANN INTERN MED
97: 242-248
[Abstract]
BILEZIKIAN, J. P.
(1982). The Medical Management of Primary Hyperparathyroidism. ANN INTERN MED
96: 198-202
[Abstract]
